Valuation: Beyond Air, Inc.

Market Cap 2.48M 2.22M 2.05M 1.86M 3.52M 233M 3.62M 24.55M 9.78M 125M 9.31M 9.11M 394M P/E 2027 *
-0.31x
P/E 2028 * -0.42x
Enterprise Value 2.48M 2.22M 2.05M 1.86M 3.52M 233M 3.62M 24.55M 9.78M 125M 9.31M 9.11M 394M EV / Sales 2027 *
0.15x
EV / Sales 2028 * 0.08x
Free-Float
87.75%
Yield 2027 *
-
Yield 2028 * -
1 day+10.28%
1 week+8.62%
Current month+12.50%
1 month+12.00%
3 months-51.54%
6 months-75.44%
Current year-82.64%
1 week 2.14
Extreme 2.14
2.63
1 month 2.05
Extreme 2.05
2.63
Current year 2.05
Extreme 2.05
53.2
1 year 2.05
Extreme 2.05
53.2
3 years 2.05
Extreme 2.05
943.96
5 years 2.05
Extreme 2.05
6,564
10 years 2.05
Extreme 2.05
6,564
Manager TitleAgeSince
Chief Executive Officer 61 2026-03-26
Director of Finance/CFO 53 2026-01-04
Chief Tech/Sci/R&D Officer - 2024-03-31
Director TitleAgeSince
Director/Board Member 58 2017-08-09
Director/Board Member 54 2018-01-01
Director/Board Member 64 2018-08-12
Date Insider Type Main position Quantity % Market Cap. Importance
10/13/26 Buy 2,607 0.2648%
10/1/26 Buy 15,393 1.5637%
9/28/26 Other 125,000 12.6980%
Change 5-day change 1-year change 3-year change Capi.($)
+10.28%+8.62%-92.76%-99.69% 2.48M
-0.05%+0.97%-12.26%+17.55% 191B
-1.17%+2.74%+9.64%+43.73% 124B
-0.44%+4.42%-8.66%+18.52% 123B
-2.43%-3.17%-41.95%+3.59% 96.14B
+0.85%+2.41%-4.37%+76.50% 66.54B
-1.23%+7.29%+17.05%-9.39% 57.91B
-1.42%+3.66%-1.82%+62.49% 54.89B
+1.47%-2.27%-4.29%+54.83% 49.1B
-5.70%-7.02%-4.64%-10.33% 36.19B
Average +0.03%+3.02%-14.41%+15.78% 80B
Weighted average by Cap. -0.83%+2.37%-7.54%+27.15%

Financials

2027 *2028 *
Net sales 16.72M 14.99M 13.82M 12.55M 23.75M 1.57B 24.41M 165M 65.91M 840M 62.73M 61.4M 2.65B 30.55M 27.4M 25.25M 22.93M 43.4M 2.86B 44.61M 302M 120M 1.53B 115M 112M 4.85B
Net income -25.45M -22.83M -21.04M -19.1M -36.16M -2.39B -37.17M -252M -100M -1.28B -95.52M -93.5M -4.04B -21.47M -19.25M -17.74M -16.11M -30.49M -2.01B -31.34M -212M -84.64M -1.08B -80.56M -78.85M -3.41B
Net Debt - -
Projected Income Statement - Annual - Beyond Air, Inc.
Logo Beyond Air, Inc.
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. Its segments include Beyond Air, Beyond Cancer, and NeuroNos. It has received United States Food and Drug Administration approval for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. The Company is advancing its other LungFit systems in clinical trials for the treatment of severe lung infections such as viral community-acquired pneumonia (including COVID-19) and nontuberculous mycobacteria. It has also partnered with The Hebrew University of Jerusalem to advance a pre-clinical program dedicated to the treatment of autism spectrum disorder and other neurological disorders. Its product pipeline includes LungFit PH, LungFit PRO, LungFit GO, and others.
Employees
54
Date Price Change Volume
26-11-10 US$2.520 +10.28% 54,970
26-11-09 US$2.285 +5.79% 22,272
26-11-06 US$2.160 -0.92% 17,579
26-11-05 US$2.180 -6.44% 21,804
26-11-04 US$2.330 +0.43% 23,915
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Beyond Air, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.520USD
Average target price
20.00USD
Spread / Average Target
+693.65%
  1. Stock Market
  2. Stocks
  3. XAIR Stock